Korea's homegrown new drug gets approval in China

Published: 2007-12-19 06:58:00
Updated: 2007-12-19 06:58:00
Ilyang Pharm has received marketing approval for ilaprazole, a new investigational proton pump inhibitor, from the Chinese drug regulatory agency (SFDA).

The ulcerant market in China has shown over 30-percent growth every year. The market for proton pump inhibitors is estimated at 700 billion,...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.